GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » InnoCan Pharma Corp (XCNQ:INNO) » Definitions » Market Cap

InnoCan Pharma (XCNQ:INNO) Market Cap : C$79.99 Mil (As of May. 14, 2024)


View and export this data going back to 2019. Start your Free Trial

What is InnoCan Pharma Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). InnoCan Pharma's share price for the quarter that ended in Dec. 2023 was C$0.31. InnoCan Pharma's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 268.00 Mil. Therefore, InnoCan Pharma's market cap for the quarter that ended in Dec. 2023 was C$83.08 Mil.

InnoCan Pharma's quarterly market cap increased from Jun. 2023 (C$63.01 Mil) to Sep. 2023 (C$86.61 Mil) but then declined from Sep. 2023 (C$86.61 Mil) to Dec. 2023 (C$83.08 Mil).

InnoCan Pharma's annual market cap declined from Dec. 2021 (C$198.80 Mil) to Dec. 2022 (C$53.69 Mil) but then increased from Dec. 2022 (C$53.69 Mil) to Dec. 2023 (C$83.08 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. InnoCan Pharma's Enterprise Value for Today is C$74.72 Mil.


InnoCan Pharma Market Cap Historical Data

The historical data trend for InnoCan Pharma's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InnoCan Pharma Market Cap Chart

InnoCan Pharma Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial 23.02 63.09 198.80 53.69 83.08

InnoCan Pharma Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 53.69 59.17 63.01 86.61 83.08

Competitive Comparison of InnoCan Pharma's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, InnoCan Pharma's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


InnoCan Pharma's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, InnoCan Pharma's Market Cap distribution charts can be found below:

* The bar in red indicates where InnoCan Pharma's Market Cap falls into.



InnoCan Pharma Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

InnoCan Pharma's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=C$0.31*268.002
=C$83.08

InnoCan Pharma's Market Cap for the quarter that ended in Dec. 2023 is calculated as

Market Cap (Q: Dec. 2023 )=Share Price (Q: Dec. 2023 )*Shares Outstanding (EOP) (Q: Dec. 2023 )
=C$0.31*268.002
=C$83.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


InnoCan Pharma  (XCNQ:INNO) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


InnoCan Pharma Market Cap Related Terms

Thank you for viewing the detailed overview of InnoCan Pharma's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


InnoCan Pharma (XCNQ:INNO) Business Description

Traded in Other Exchanges
Address
1015, 926 - 5 Avenue SW, Calgary, AB, CAN, T2P 0N7
InnoCan Pharma Corp is a pharmaceutical tech company that focuses on the development of several drug delivery platforms combining cannabidiol with other pharmaceutical ingredients as well as the development and sale of CBD-integrated pharmaceuticals. Geographically, it derives a majority of its revenue from the United States.

InnoCan Pharma (XCNQ:INNO) Headlines

From GuruFocus

President of Innocap, Inc. is in Singapore

By Marketwired Marketwired 05-03-2018

President of Innocap, Inc. is in Singapore

By GlobeNewswire GlobeNewswire 05-03-2018

Innocap, Inc. Year End Message To Shareholders

By PRNewswire PRNewswire 12-14-2020

Innocap, Inc.'s Current Activities

By Marketwired Marketwired 05-24-2018